Radiation boost for melanoma cell therapy shows mixed results
NCT ID NCT01319565
First seen Jan 05, 2026 · Last updated Apr 25, 2026 · Updated 16 times
Summary
This study tested whether adding total body irradiation (TBI) to standard chemotherapy before giving patients their own lab-grown immune cells could improve outcomes for metastatic melanoma. 102 adults with advanced skin cancer were randomly assigned to receive either chemotherapy alone or chemotherapy plus low-dose radiation before the cell infusion. The goal was to see which approach led to better tumor shrinkage and longer survival. While the treatment showed promise, patients needed long-term antibiotics and monitoring, and the approach is not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.